KK
AVBP icon

KLP Kapitalforvaltning’s ArriVent BioPharma AVBP Stock Holding History

KLP Kapitalforvaltning’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
8,200
+3,900
+91% +$115K ﹤0.01% 1747
2026
Q1 		$99.2K Hold
4,300
– – ﹤0.01% 2054
2025
Q4 		$86.5K Buy
4,300
+1,200
+39% +$25K ﹤0.01% 2105
2025
Q3 		$57.2K Hold
3,100
– – ﹤0.01% 2142
2025
Q2 		$67.5K Hold
3,100
– – ﹤0.01% 2121
2025
Q1 		$57.3K Hold
3,100
– – ﹤0.01% 2175
2024
Q4 		$82.6K Buy
+3,100
New +$89K ﹤0.01% 2145

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KLP Kapitalforvaltning's AVBP Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its ArriVent BioPharma (AVBP) stake by 91% in Q2 2026, buying an estimated $115K and bringing the position to 8,200 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

KLP Kapitalforvaltning first reported a position in AVBP in Q4 2024 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • KLP Kapitalforvaltning held 8,200 shares of ArriVent BioPharma worth $285K as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,900 ArriVent BioPharma shares in Q2 2026, an estimated $115K.
  • ArriVent BioPharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1747 holding.
  • KLP Kapitalforvaltning first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.